NCT04905108View on ClinicalTrials.gov

Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia

PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
KeratoconusCorneal Ectasia
Interventions
DRUG

Riboflavin

Administration of riboflavin one drop every 2 minutes during UVA exposure

DRUG

Riboflavin

Administration of riboflavin one drop every 10 minutes during UVA exposure

Trial Locations (1)

07666

RECRUITING

Cornea and Laser Eye Institute, Hersh Vision Group, Teaneck

All Listed Sponsors
lead

Cornea and Laser Eye Institute

OTHER

NCT04905108 - Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia | Biotech Hunter | Biotech Hunter